Indication
Complement hyperactivation angiopathic thrombosis protein losing enteropathy
Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy (commonly referred to as CHAPLE syndrome or CD55 deficiency) is an ultra-rare, monogenic immune and gastrointestinal disorder inherited in an autosomal recessive pattern. Read more about Complement hyperactivation angiopathic thrombosis protein losing enteropathy
1 drugs 1 manufacturers
Drugs that treat it
Common Complement hyperactivation angiopathic thrombosis protein losing enteropathy therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonComplement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy (commonly referred to as CHAPLE syndrome or CD55 deficiency) is an ultra-rare, monogenic immune and gastrointestinal disorder inherited in an autosomal recessive pattern.
The condition primarily manifests in infancy or early childhood and stems from loss-of-function mutations in the *CD55* gene (decay-accelerating factor), resulting in uncontrolled terminal complement cascade activation.
This complement dysregulation induces microvascular injury and intestinal lymphangiectasia, culminating in severe gastrointestinal protein loss, hypoalbuminemia, and peripheral edema.
Patients frequently experience chronic abdominal pain, malabsorption, malnutrition, recurrent infections due to hypogammaglobulinemia, and potentially life-threatening angiopathic thromboembolic occlusions.
- orpha.net
Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy (commonly referred to as CHAPLE syndrome or CD55 deficiency) is an ultra-rare, monogenic immune and gastrointestinal disorder inherited in an autosomal recessive pattern This complement dysregulation induces microvascular injury and intestinal lymphangiectasia, culminating in severe gastrointestinal protein loss, hypoalbuminemia, and peripheral edema Patients frequently experience chronic abdominal pain, malabsorp...
- tandfonline.com
Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy (commonly referred to as CHAPLE syndrome or CD55 deficiency) is an ultra-rare, monogenic immune and gastrointestinal disorder inherited in an autosomal recessive pattern
- firstwordpharma.com
Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy (commonly referred to as CHAPLE syndrome or CD55 deficiency) is an ultra-rare, monogenic immune and gastrointestinal disorder inherited in an autosomal recessive pattern The condition primarily manifests in infancy or early childhood and stems from loss-of-function mutations in the *CD55* gene (decay-accelerating factor), resulting in uncontrolled terminal complement cascade activation
- wikipedia.org
The condition primarily manifests in infancy or early childhood and stems from loss-of-function mutations in the *CD55* gene (decay-accelerating factor), resulting in uncontrolled terminal complement cascade activation This complement dysregulation induces microvascular injury and intestinal lymphangiectasia, culminating in severe gastrointestinal protein loss, hypoalbuminemia, and peripheral edema Patients frequently experience chronic abdominal pain, malabsorption, malnutrition, recurrent infe...
- nih.gov
This complement dysregulation induces microvascular injury and intestinal lymphangiectasia, culminating in severe gastrointestinal protein loss, hypoalbuminemia, and peripheral edema
- globalgenes.org
Patients frequently experience chronic abdominal pain, malabsorption, malnutrition, recurrent infections due to hypogammaglobulinemia, and potentially life-threatening angiopathic thromboembolic occlusions
Personalize your experience
Follow Complement hyperactivation angiopathic thrombosis protein losing enteropathy and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.